TELDRIN Drug Patent Profile
✉ Email this page to a colleague
When do Teldrin patents expire, and when can generic versions of Teldrin launch?
Teldrin is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in TELDRIN is chlorpheniramine maleate. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Teldrin
A generic version of TELDRIN was approved as chlorpheniramine maleate by AVANTHI INC on May 13th, 2009.
Summary for TELDRIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 46 |
Patent Applications: | 4,312 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TELDRIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TELDRIN
US Patents and Regulatory Information for TELDRIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | TELDRIN | chlorpheniramine maleate | CAPSULE, EXTENDED RELEASE;ORAL | 017369-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | TELDRIN | chlorpheniramine maleate | CAPSULE, EXTENDED RELEASE;ORAL | 017369-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |